Published in Nat Rev Cardiol on February 09, 2010
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med (2012) 3.77
Sudden cardiac arrest in people with epilepsy in the community: Circumstances and risk factors. Neurology (2015) 1.54
Warning Symptoms Are Associated With Survival From Sudden Cardiac Arrest. Ann Intern Med (2016) 1.49
Iron-Sensitive Cardiac Magnetic Resonance Imaging for Prediction of Ventricular Arrhythmia Risk in Patients With Chronic Myocardial Infarction: Early Evidence. Circ Cardiovasc Imaging (2015) 1.43
Long-term prognosis associated with J-point elevation in a large middle-aged biracial cohort: the ARIC study. Eur Heart J (2011) 1.29
Common genetic variants associated with sudden cardiac death: the FinSCDgen study. PLoS One (2012) 1.04
Conduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions. Int J Cardiol Heart Vasc (2015) 1.00
Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study. J Cardiovasc Electrophysiol (2012) 0.98
Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse hearts. Biomed Rep (2016) 0.95
Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis. Am J Physiol Regul Integr Comp Physiol (2012) 0.94
Negative autopsy and sudden cardiac death. Int J Legal Med (2014) 0.93
Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease. PLoS One (2013) 0.87
Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population. Ann Med (2013) 0.85
Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med (2012) 0.85
Sudden cardiac death in South India: Incidence, risk factors and pathology. Indian Pacing Electrophysiol J (2016) 0.85
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J (2014) 0.84
Nonesterified fatty acids and risk of sudden cardiac death in older adults. Circ Arrhythm Electrophysiol (2012) 0.82
Overexpression of M₃ muscarinic receptor is a novel strategy for preventing sudden cardiac death in transgenic mice. Mol Med (2011) 0.82
High sugar intake exacerbates cardiac reperfusion injury in perinatal taurine depleted adult rats. J Biomed Sci (2010) 0.80
Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities. Curr Opin Pharmacol (2014) 0.79
Targeted antioxidant treatment decreases cardiac alternans associated with chronic myocardial infarction. Circ Arrhythm Electrophysiol (2014) 0.79
Noninvasive reconstruction of cardiac electrical activity: update on current methods, applications and challenges. Neth Heart J (2015) 0.78
Trends in sudden cardiac death and its risk factors in Japan from 1981 to 2005: the Circulatory Risk in Communities Study (CIRCS). BMJ Open (2012) 0.78
Myocardial electrotonic response to submaximal exercise in dogs with healed myocardial infarctions: evidence for β-adrenoceptor mediated enhanced coupling during exercise testing. Front Physiol (2015) 0.78
Sudden Unexpected Death in North Carolina (SUDDEN): methodology review and screening results. Open Heart (2014) 0.77
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential. Heart Fail Rev (2015) 0.77
Variation of mortality after coronary artery bypass surgery in relation to hour, day and month of the procedure. BMC Cardiovasc Disord (2011) 0.77
Cumulative effects of common genetic variants on risk of sudden cardiac death. Int J Cardiol Heart Vasc (2015) 0.76
Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes. Basic Res Cardiol (2016) 0.75
Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition ameliorates arrhythmias elicited by junctin ablation under stress conditions. Heart Rhythm (2015) 0.75
Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction. J Geriatr Cardiol (2016) 0.75
Incidence of sudden cardiac death in a young active population. J Am Heart Assoc (2015) 0.75
Cold spells and ischaemic sudden cardiac death: effect modification by prior diagnosis of ischaemic heart disease and cardioprotective medication. Sci Rep (2017) 0.75
Sudden cardiac death in low- and middle-income countries. Glob Heart (2012) 0.75
Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram. J Cardiovasc Electrophysiol (2010) 0.75
Molecular autopsy in victims of inherited arrhythmias. J Arrhythm (2015) 0.75
Molecular genetic diagnostics for ventricular arrhythmias and sudden cardiac death syndromes. Herz (2017) 0.75
A novel method of standardized myocardial infarction in aged rabbits. Am J Physiol Heart Circ Physiol (2017) 0.75
Sudden Arrhythmic Death During Exercise: A Post-Mortem Genetic Analysis. Sports Med (2017) 0.75
Circadian pattern of short-term variability of the QT-interval in primary prevention ICD patients - EU-CERT-ICD methodological pilot study. PLoS One (2017) 0.75
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Sudden cardiac death. Circulation (1998) 9.41
State of disparities in cardiovascular health in the United States. Circulation (2005) 9.32
Sudden cardiac death in the United States, 1989 to 1998. Circulation (2001) 7.92
Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med (2004) 7.27
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med (2000) 6.42
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation (2006) 5.47
The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol (2005) 5.33
Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA (2002) 5.19
Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med (1997) 5.09
Public use of automated external defibrillators. N Engl J Med (2002) 5.07
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 4.51
Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol (2004) 4.44
Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (2002) 4.40
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation (2002) 4.30
Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis (2008) 4.09
Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol (1997) 4.00
Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 3.80
Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol (2008) 3.73
Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol (2006) 3.44
QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation (1991) 3.25
Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation (2004) 3.12
Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation (2001) 3.08
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol (2007) 2.90
Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation (2007) 2.82
Psychosocial influences on mortality after myocardial infarction. N Engl J Med (1984) 2.72
Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med (2003) 2.68
Racial differences in survival after in-hospital cardiac arrest. JAMA (2009) 2.65
Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation (2006) 2.63
Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol (2006) 2.59
Outcome of out-of-hospital cardiac arrest in New York City. The Pre-Hospital Arrest Survival Evaluation (PHASE) Study. JAMA (1994) 2.58
Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J (2000) 2.52
Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc (2004) 2.40
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation (2009) 2.34
Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation (2009) 2.31
Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation (2005) 2.25
Sudden death after myocardial infarction. JAMA (2008) 2.24
Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation (2006) 2.24
Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA (1992) 2.22
Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol (2003) 2.06
Public locations of cardiac arrest. Implications for public access defibrillation. Circulation (1998) 1.97
QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm (2005) 1.96
Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation (1995) 1.95
Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J (2005) 1.88
How sudden is sudden cardiac death? Circulation (2006) 1.88
Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res (2005) 1.86
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA (2009) 1.80
Experiences from treatment of out-of-hospital cardiac arrest during 17 years in Göteborg. Eur Heart J (2000) 1.79
Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation (2009) 1.74
Seasonality and daily weather conditions in relation to myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, 1979 to 2002. J Am Coll Cardiol (2006) 1.73
Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J (2010) 1.70
Anatomic features in victims of sudden coronary death. Coronary artery pathology. Circulation (1992) 1.68
Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J (2003) 1.67
Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation (2007) 1.67
Comparison of naive sixth-grade children with trained professionals in the use of an automated external defibrillator. Circulation (1999) 1.66
Annual distribution of ventricular tachycardias and ventricular fibrillation. Am Heart J (2003) 1.56
Temporal patterns in long-term survival after resuscitation from out-of-hospital cardiac arrest. Circulation (2003) 1.54
Sudden cardiac death with apparently normal heart. Circulation (2000) 1.52
Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation (2007) 1.50
Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol (1995) 1.48
Validation of death certificate diagnosis of out-of-hospital sudden cardiac death. Am J Cardiol (1998) 1.48
Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation (2009) 1.47
Cardiac failure and sudden death in the Framingham Study. Am Heart J (1988) 1.46
Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol (2005) 1.45
Validation of death certificate diagnosis of out-of-hospital coronary heart disease deaths in Olmsted County, Minnesota. Mayo Clin Proc (2000) 1.45
Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol (1988) 1.42
The epidemiology of out-of-hospital 'sudden' cardiac arrest. Resuscitation (2002) 1.41
Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol (2004) 1.39
Fragmented QRS: a predictor of mortality and sudden cardiac death. Heart Rhythm (2008) 1.38
Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation (2004) 1.37
Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation (2006) 1.35
Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis (2002) 1.34
Defibrillators in public places--one step closer to home. N Engl J Med (2002) 1.31
Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol (1984) 1.29
Long- and short-term risk of sudden coronary death. Circulation (1992) 1.28
Incidence of sudden cardiac arrest is higher in areas of low socioeconomic status: a prospective two year study in a large United States community. Resuscitation (2006) 1.25
Genetic determinants of sudden cardiac death. Circulation (2008) 1.22
Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol (1992) 1.21
Seven years' experience with early defibrillation by police and paramedics in an emergency medical services system. Resuscitation (1998) 1.20
Incidence of sudden cardiac death in China: analysis of 4 regional populations. J Am Coll Cardiol (2009) 1.19
A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol (2005) 1.16
Geographical distribution of cardiac arrest in Nottinghamshire. Resuscitation (2001) 1.16
Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J (2008) 1.15
Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation (1995) 1.13
Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation (1996) 1.11
Scientific gaps in the prediction and prevention of sudden cardiac death. J Cardiovasc Electrophysiol (2002) 1.08
Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med (2003) 1.07
Multiple source surveillance incidence and aetiology of out-of-hospital sudden cardiac death in a rural population in the West of Ireland. Eur Heart J (2008) 1.06
Sudden cardiac death: better understanding of risks, mechanisms, and treatment. Circulation (2006) 1.05
Sudden cardiac death in Hispanic Americans and African Americans. Am J Public Health (1997) 1.05
Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm (2008) 1.05
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation (2001) 1.01
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78
Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med (2008) 5.86
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A (2006) 4.56
Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol (2002) 4.56
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation (2012) 4.13
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med (2012) 3.77
The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol (2004) 3.61
Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation (2007) 3.57
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 3.47
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Natural history of asymptomatic mitral valve prolapse in the community. Circulation (2002) 3.40
Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40
Controversies in ventricular remodelling. Lancet (2006) 3.39
Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol (2003) 3.20
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13
Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol (2003) 3.09
Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99
Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol (2012) 2.98
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol (2013) 2.90
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Controversies in stable coronary artery disease. Lancet (2006) 2.88
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet (2009) 2.82
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol (2008) 2.74
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum (2005) 2.74
Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol Genet Metab (2005) 2.72
Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med (2003) 2.68
Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation (2010) 2.64
Atrial fibrillation and death after myocardial infarction: a community study. Circulation (2011) 2.63
Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation (2011) 2.63
Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation (2005) 2.61
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol (2006) 2.55
Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail (2012) 2.53
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2011) 2.53
Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol (2004) 2.52
Trends in cause of death after percutaneous coronary intervention. Circulation (2014) 2.52
Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol (2002) 2.50
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J Am Coll Cardiol (2011) 2.49
Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation (2007) 2.47
Death in heart failure: a community perspective. Circ Heart Fail (2008) 2.46
Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J (2008) 2.44
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (2005) 2.43
Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation (2008) 2.42
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol (2009) 2.34
Coronary heart disease death and sudden cardiac death: a 20-year population-based study. Am J Epidemiol (2003) 2.34
Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol (2007) 2.32
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Syncope while driving: clinical characteristics, causes, and prognosis. Circulation (2009) 2.30
Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J (2006) 2.26
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail (2012) 2.26
Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol (2004) 2.25
Sudden death after myocardial infarction. JAMA (2008) 2.24
Secular trends in deaths from cardiovascular diseases: a 25-year community study. Circulation (2006) 2.24
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation (2007) 2.20
The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol (2003) 2.19
Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes (2010) 2.19
Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care (2007) 2.18
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol (2010) 2.15
Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc (2004) 2.11
Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med (2006) 2.09
Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc (2002) 2.08
Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation (2002) 2.07